Elevance Health Files 8-K on Operations & Financials

Ticker: ELV · Form: 8-K · Filed: 2025-04-17T00:00:00.000Z

Sentiment: neutral

Topics: disclosure, financials

Related Tickers: ELV

TL;DR

Elevance Health dropped an 8-K on April 17th about their financials. Keep an eye on this.

AI Summary

Elevance Health, Inc. filed an 8-K on April 17, 2025, to report on its results of operations and financial condition, as well as a Regulation FD disclosure. The filing does not contain specific financial figures or forward-looking statements within the provided text, but indicates a formal reporting event.

Why It Matters

This filing signals that Elevance Health is providing updated information regarding its financial performance and operational status to the public, which is crucial for investors to assess the company's health.

Risk Assessment

Risk Level: low — The filing is a standard disclosure and does not contain any immediately alarming information or significant negative events.

Key Players & Entities

FAQ

What specific financial results or operational updates are being disclosed by Elevance Health in this 8-K filing?

The provided text of the 8-K filing does not contain specific financial figures or detailed operational updates. It only indicates that the filing pertains to 'Results of Operations and Financial Condition' and 'Regulation FD Disclosure'.

When was the earliest event reported in this 8-K filing?

The earliest event reported in this 8-K filing is April 17, 2025, which is also the date of the report.

What is Elevance Health's principal executive office address?

Elevance Health's principal executive offices are located at 220 Virginia Ave, Indianapolis, IN 46204.

Has Elevance Health changed its name previously?

Yes, Elevance Health was formerly known as Anthem, Inc. (name change effective December 2, 2014), and prior to that, WELLPOINT, INC (name change effective January 5, 2010), and WELLPOINT INC (name change effective November 30, 2004).

What is the SIC code for Elevance Health, Inc.?

The Standard Industrial Classification (SIC) code for Elevance Health, Inc. is 6324, which corresponds to HOSPITAL & MEDICAL SERVICE PLANS.

From the Filing

0001156039-25-000051.txt : 20250417 0001156039-25-000051.hdr.sgml : 20250417 20250417102415 ACCESSION NUMBER: 0001156039-25-000051 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 14 CONFORMED PERIOD OF REPORT: 20250417 ITEM INFORMATION: Results of Operations and Financial Condition ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20250417 DATE AS OF CHANGE: 20250417 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Elevance Health, Inc. CENTRAL INDEX KEY: 0001156039 STANDARD INDUSTRIAL CLASSIFICATION: HOSPITAL & MEDICAL SERVICE PLANS [6324] ORGANIZATION NAME: 02 Finance EIN: 352145715 STATE OF INCORPORATION: IN FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-16751 FILM NUMBER: 25845475 BUSINESS ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 BUSINESS PHONE: 8003311476 MAIL ADDRESS: STREET 1: 220 VIRGINIA AVENUE CITY: INDIANAPOLIS STATE: IN ZIP: 46204 FORMER COMPANY: FORMER CONFORMED NAME: Anthem, Inc. DATE OF NAME CHANGE: 20141202 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT, INC DATE OF NAME CHANGE: 20100105 FORMER COMPANY: FORMER CONFORMED NAME: WELLPOINT INC DATE OF NAME CHANGE: 20041130 8-K 1 elv-20250417.htm 8-K elv-20250417 FALSE 0001156039 0001156039 2025-04-17 2025-04-17 UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 ___________________________________ FORM 8-K ___________________________________ CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 April 17, 2025 Date of Report (Date of earliest event reported) ___________________________________ Elevance Health, Inc. (Exact name of registrant as specified in its charter) ___________________________________ Indiana (State or other jurisdiction of incorporation or organization) 001-16751 (Commission File Number) 35-2145715 (I.R.S. Employer Identification Number) 220 Virginia Ave Indianapolis , IN 46204 (Address of principal executive offices and zip code) ( 833 ) 401-1577 (Registrant's telephone number, including area code) ________________ Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions: ☐ Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) ☐ Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) ☐ Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) ☐ Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) Securities registered pursuant to Section 12(b) of the Act: Title of each class Trading Symbol Name of each exchange on which registered Common Stock, Par Value $0.01 ELV NYSE Indicate by check mark whether the registrant is an emerging growth company as defined Rule 405 of the Securities Act (§230.405 of this chapter) or Rule 12b-2 of the Exchange Act (§240.12b-2 of this chapter). Emerging growth company     ☐ If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. Item 2.02 - Results of Operations and Financial Condition. Item 7.01 - Regulation FD Disclosure. Elevance Health, Inc. (the “Company”) will release its first quarter 2025 financial results on April 22, 2025. The Company expects to report first quarter GAAP shareholders’ net income of $9.61 per diluted share, including approximately $2.36 per diluted share of net unfavorable items. Excluding these items, adjusted shareholders’ net income was $11.97 per diluted share. First quarter results reflect medical cost trends that developed in line with the Company’s expectations, including in its Medicare Ad

View on Read The Filing